CDC, FDA recommend pause in Johnson & Johnson COVID vaccine after reports of rare blood clots
he federal agencies said they were investigating clots in six women in the days after they received the vaccination
The Facts Inside Our Reporter’s Notebook
The CDC and FDA on Tuesday recommended a "pause" in administering single-dose Johnson & Johnson COVID-19 vaccine in the United State until they can fully investigate reports of potentially dangerous blood clots.
In a joint statement, the federal agencies said they were investigating clots in six women in the days after they received the vaccination, according to the Associated Press.
The CDC’s Advisory Committee on Immunization Practices will meet Wednesday to discuss the cases, and the FDA has also launched an investigation of the cases.
“Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr. Anne Schuchat, principal deputy director of the CDC and Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research said in a joint statement, obtained by the wire service.
News, Not Noise
- Investigation finds massive wrongdoing by prosecutor in case against ex-Missouri governor
- Biden issues National Day of Prayer Proclamation that does not include the word 'God'
- Fauci's agency spent over $400k on experiments grafting aborted fetal scalps onto mice and rats
- Kansas GOP lawmakers override Democratic governor's vetos on election bills, make them into law
- Arizona GOP chairwoman rejects election audit attacks: 'World-class experts' conducting review